Freepik
    Moscow, Russia - November 7, 2021: PFIZER S NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE REDUCED RISK OF HOSPITALIZATION OR DEATH BY 89 IN INTERIM ANALYSIS OF PHASE 2 3 EPIC-HR STUDY

    Moscow, Russia - November 7, 2021: PFIZER S NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE REDUCED RISK OF HOSPITALIZATION OR DEATH BY 89 IN INTERIM ANALYSIS OF PHASE 2 3 EPIC-HR STUDY

    Related tags: